PIK3CA c.167A>C ;(p.Y56S)

Variant ID: 3-178916780-A-C

NM_006218.2(PIK3CA):c.167A>C;(p.Y56S)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


MiRNA therapeutics based on logic circuits of biological pathways.

Bmc Bioinformatics
Boscaino, Valeria V; Fiannaca, Antonino A; La Paglia, Laura L; La Rosa, Massimo M; Rizzo, Riccardo R; Urso, Alfonso A
Publication Date: 2019-11-22

Variant appearance in text: PIK3CA: 167A>C
PubMed Link: 31757209
Variant Present in the following documents:
  • Main text
View BVdb publication page



MEK inhibitor enhanced the antitumor effect of oxaliplatin and 5‑fluorouracil in MEK1 Q56P‑mutant colorectal cancer cells.

Molecular Medicine Reports
Jing, Changwen C; Li, Huizi H; Du, Yuanyuan Y; Cao, Haixia H; Liu, Siwen S; Wang, Zhuo Z; Ma, Rong R; Feng, Jifeng J; Wu, Jianzhong J
Publication Date: 2019-02

Variant appearance in text: PIK3CA: 167A>C
PubMed Link: 30535504
Variant Present in the following documents:
  • mmr-19-02-1092.pdf
View BVdb publication page



VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research.

Nucleic Acids Research
Lai, Zhongwu Z; Markovets, Aleksandra A; Ahdesmaki, Miika M; Chapman, Brad B; Hofmann, Oliver O; McEwen, Robert R; Johnson, Justin J; Dougherty, Brian B; Barrett, J Carl JC; Dry, Jonathan R JR
Publication Date: 2016-06-20

Variant appearance in text: PIK3CA: 167A>C; Y56S
PubMed Link: 27060149
Variant Present in the following documents:
  • supp_gkw227_nar-03544-met-k-2015-File003.xls, sheet 2
View BVdb publication page



Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma.

Ebiomedicine
O'Donnell, Elizabeth E; Mahindra, Anuj A; Yee, Andrew J AJ; Nardi, Valentina V; Birrer, Nicole N; Horick, Nora N; Borger, Darrell D; Finkelstein, Dianne D; Iafrate, John A JA; Raje, Noopur N
Publication Date: 2015-01

Variant appearance in text: PIK3CA: 167A>C
PubMed Link: 26137536
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page